Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
Zlotta AR, Ballas LK, Niemierko A, Lajkosz K, Kuk C, Miranda G, Drumm M, Mari A, Thio E, Fleshner NE, Kulkarni GS, Jewett MAS, Bristow RG, Catton C, Berlin A, Sridhar SS, Schuckman A, Feldman AS, Wszolek M, Dahl DM, Lee RJ, Saylor PJ, Michaelson MD, Miyamoto DT, Zietman A, Shipley W, Chung P, Daneshmand S, Efstathiou JA. Zlotta AR, et al. Among authors: mari a. Lancet Oncol. 2023 Jun;24(6):669-681. doi: 10.1016/S1470-2045(23)00170-5. Epub 2023 May 12. Lancet Oncol. 2023. PMID: 37187202
Radical cystectomy in bladder cancer patients previously treated for prostate cancer: Insights from a large European multicentric series.
Tappero S, Chierigo F, Parodi S, Bandini M, Moschini M, Cucchiara V, Chessa F, Di Maida F, Mari A, Manfredi M, Mantica G, Cerruto MA, Fiori C, Schiavina R, Briganti A, Suardi N, Brunocilla E, Antonelli A, Porpiglia F, Minervini A, Montorsi F, Terrone C. Tappero S, et al. Among authors: mari a. Surg Oncol. 2023 Oct;50:101973. doi: 10.1016/j.suronc.2023.101973. Epub 2023 Jul 11. Surg Oncol. 2023. PMID: 37454433
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapy.
Piszczek R, Krajewski W, Subiela JD, Del Giudice F, Nowak Ł, Chorbińska J, Moschini M, Masson-Lecomte A, Bebane S, Cimadamore A, Grobet-Jeandin E, Rouprêt M, D'Andrea D, Mastroianni R, Gutierrez Hidalgo B, Gomez Rivas J, Mori K, Soria F, Laukhtina E, Mari A, Albisinni S, Gallioli A, Mertens LS, Pichler R, Marcq G, Łaszkiewicz J, Hałoń A, Carrion DM, Akand M, Pradere B, Shariat SF, Palou J, Babjuk M, Burgos Revilla J, Małkiewicz B, Szydełko T; European Association of Urology EAU-Young Academic Urologists YAU Urothelial Cancer Working Party. Piszczek R, et al. Among authors: mari a. Minerva Urol Nephrol. 2023 Oct;75(5):591-599. doi: 10.23736/S2724-6051.23.05418-6. Minerva Urol Nephrol. 2023. PMID: 37728495 Free article.
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database.
Porreca A, Di Nicola M, Lucarelli G, Dorin VM, Soria F, Terracciano D, Mistretta FA, Luzzago S, Buonerba C, Cantiello F, Mari A, Minervini A, Veccia A, Antonelli A, Musi G, Hurle R, Busetto GM, Del Giudice F, Ferretti S, Perdonà S, Prete PD, Porreca A, Bove P, Crisan N, Russo GI, Damiano R, Amparore D, Porpiglia F, Autorino R, Piccinelli M, Brescia A, Tătaru SO, Crocetto F, Giudice AL, de Cobelli O, Schips L, Ferro M, Marchioni M. Porreca A, et al. Among authors: mari a. Urol Oncol. 2024 Mar;42(3):69.e17-69.e25. doi: 10.1016/j.urolonc.2024.01.001. Epub 2024 Feb 1. Urol Oncol. 2024. PMID: 38302296 Free article.
Minimally invasive transperitoneal partial versus radical nephrectomy in obese patients: perioperative and long-term functional outcomes from a large perspective contemporary series (RECORd2 project).
Lambertini L, Mari A, Sandulli A, Amparore D, Antonelli A, Barale M, Bove P, Brunocilla E, Capitanio U, DA Pozzo LF, DI Maida F, Grosso AA, Fiori C, Gontero P, Li Marzi V, Campi R, Longo N, Marchioni M, Montanari E, Montorsi F, Porpiglia F, Porreca A, Schiavina R, Simeone C, Siracusano S, Terrone C, Ficarra V, Minervini A. Lambertini L, et al. Among authors: mari a. Minerva Urol Nephrol. 2024 Apr;76(2):185-194. doi: 10.23736/S2724-6051.24.05692-1. Minerva Urol Nephrol. 2024. PMID: 38742553 Free article.
Assessing the Trade-off Between the Safety and Effectiveness of Off-clamp Robotic Partial Nephrectomy for Renal Masses with a High RENAL Score: A Propensity Score-matched Comparison of Perioperative and Functional Outcomes in a Multicenter Analysis.
Tuderti G, Mastroianni R, Anceschi U, Bove AM, Brassetti A, Ferriero M, Misuraca L, Guaglianone S, Costantini M, Torregiani G, Saidian A, Mari A, Narasimhan R, Derweesh I, Minervini A, Gallucci M, Simone G. Tuderti G, et al. Among authors: mari a. Eur Urol Focus. 2023 Nov;9(6):1037-1043. doi: 10.1016/j.euf.2023.05.009. Epub 2023 May 30. Eur Urol Focus. 2023. PMID: 37263828
Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomy.
D'Andrea D, Shariat SF, Soria F, DI Trapani E, Mertens LS, VAN Rhijn BW, Dinney CP, Black PC, Spiess PE, Carrion DM, Pradere B, Tonin E, Pichler R, Filippot R, Mari A, Moschini M; European Association of Urology-Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. D'Andrea D, et al. Among authors: mari a. Minerva Urol Nephrol. 2023 Aug;75(4):452-459. doi: 10.23736/S2724-6051.23.05289-8. Epub 2023 Jun 14. Minerva Urol Nephrol. 2023. PMID: 37314813 Free article.
Morbidity of elective surgery for localized renal masses among elderly patients: A contemporary multicenter study.
Borregales LD, Pecoraro A, Roussel E, Mari A, Grosso AA, Checcucci E, Montorsi F, Larcher A, Van Poppel H, Porpiglia F, Capitanio U, Minervini A, Albersen M, Serni S, Amparore D, Campi R. Borregales LD, et al. Among authors: mari a. Eur J Surg Oncol. 2023 Oct;49(10):107014. doi: 10.1016/j.ejso.2023.107014. Epub 2023 Aug 9. Eur J Surg Oncol. 2023. PMID: 37573666
Could a Risk-adapted Approach Support Shared Decision-making Regarding Eligibility for Adjuvant Pembrolizumab for Patients with Clear Cell Renal Cell Carcinoma at High Risk of Recurrence? A Multicentre Cohort Study.
Campi R, Pecoraro A, Roussel E, Amparore D, Mari A, Montorsi F, Porpiglia F, Albersen M, Capitanio U, Minervini A, Serni S, Bertolo R. Campi R, et al. Among authors: mari a. Eur Urol Oncol. 2024 Jun;7(3):323-327. doi: 10.1016/j.euo.2023.10.023. Epub 2023 Nov 8. Eur Urol Oncol. 2024. PMID: 37945489
1,148 results